Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — April 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #2

    Afsnit 59 af Investeringspodcasten om oplukningsstrategi og markedsbevægelser: https://www.proinvestor.com/index.php?p=debat_1&postid=92493

    1 Reply Last reply
    0
    • U Offline
      U Offline
      ungeee
      wrote on sidst redigeret af
      #3

      21401 er kursen på GEN snart i følge seneste video TA-analyse fra TimerMarket

      1 Reply Last reply
      0
      • nohopeN Offline
        nohopeN Offline
        nohope
        wrote on sidst redigeret af
        #4

        Mon dog - mon dog -

        1 Reply Last reply
        0
        • L Offline
          L Offline
          lahn1
          wrote on sidst redigeret af
          #5

          Aprilsnar eller for meget påskebryg 🙂

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #6

            BTK: Amerikansk biotech lægger an til positiv trendvending efter lang nedtur https://www.proinvestor.com/investornyt/673713/btk-amerikansk-biotech-laegger-an-til-positiv-trendvending-efter-lang-nedtur

            1 Reply Last reply
            0
            • K Offline
              K Offline
              Klarussen
              wrote on sidst redigeret af
              #7

              @ungeee: snarlig upside på 925%, lyder meget godt... men
              1000% var bedre.

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #8

                HexaBody®-CD38 also on clinicaltrials now https://www.clinicaltrials.gov/ct2/show/NCT04824794

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #9

                  Just a moment...

                  favicon

                  (www.firstwordpharma.com)

                  1 Reply Last reply
                  0
                  • U Offline
                    U Offline
                    ungeee
                    wrote on sidst redigeret af
                    #10

                    11.55, 12.31 11.26 - 210401 ville heller ikke være så tosset....og så undskyld til alle for mit uheldige forsøg 🙂 - god påske

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #11

                      God morgen. 🙂

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #12

                        GEN1046 Anticipated Enrollment ; large increase from 192 to 512
                        https://clinicaltrials.gov/ct2/history/NCT03917381?A=12&B=13&C=merged#StudyPageTop

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #13

                          this Amivantamab trial adds a chemo cohort https://clinicaltrials.gov/ct2/history/NCT04077463?A=17&B=18&C=merged#StudyPageTop

                          1 Reply Last reply
                          0
                          • JørgenVarnæsJ Offline
                            JørgenVarnæsJ Offline
                            JørgenVarnæs
                            wrote on sidst redigeret af
                            #14

                            Wow! Rather a large phase 1/2 study!!!

                            1 Reply Last reply
                            0
                            • JørgenVarnæsJ Offline
                              JørgenVarnæsJ Offline
                              JørgenVarnæs
                              wrote on sidst redigeret af
                              #15

                              That corresponds well with the optimal dose-statements made by biontech, you found a couple of days ago

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #16

                                yes, seems like a similar strategy as epcoritamab, also close to 500 in the Ph 1/2

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #17

                                  small new Dara
                                  trial for prospective kidney transplant recipients Daratumumab and Belatacept for Desensitization (ATTAIN) https://clinicaltrials.gov/ct2/show/NCT04827979

                                  1 Reply Last reply
                                  0
                                  • SolsenS Offline
                                    SolsenS Offline
                                    Solsen
                                    wrote on sidst redigeret af
                                    #18

                                    I Gen1046 ændrer man protokol til også at indbefatte docetaxel. Det skulle vi spørge til ved næste Q&A.

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #19

                                      En godkendelse til isa https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-isatuximab-irfc-multiple-myeloma?utm_medium=email&utm_source=govdelivery Ved ikke om det er en gammel nyhed på PI

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #20

                                        Considering the attractiv evaluation, upcoming news flow on key pipeline programs epcoritamab, tisotumab,and GEN1046, and seeing Genmab as one of those typical stocks to own when markets are jittery, we add Genmab to our best value list. https://www.proinvestor.com/index.php?p=debat_1&postid=92506

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #21

                                          Ja, meget kunne have set anderledes ud, hvis de ikke havde været så fedtede med guidance. Min ser således ud: us/row Q1 725/600 - Q2 775/650 - Q3 825/700 - Q4 875/775 - Y 3200/2725 - Total 5925. Endda forsigtig synes jeg. Hvordan ser jeres ud?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger